GlassScriptPhysician profile
Julie Deaun Graves
NPI 1093794265
$3,274.33
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.91 · 2020: $45.21 · 2022: $27.94 · 2023: $3,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,038 · Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,037.50 |
| Food and Beverage | $104.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $3,037.50 | 2023 | |
| Glaxosmithkline, LLC. | $70.18 | 2019-2020 | |
| Novo Nordisk INC | $58.17 | 2022-2023 | Rybelsus, Ozempic |
| Viiv Healthcare Company | $38.62 | 2023 | Apretude |
| Janssen Biotech, INC. | $20.83 | 2023 | Symtuza |
| Antares Pharma, INC. | $18.98 | 2020 | |
| Theratechnologies INC. | $15.09 | 2023 | Trogarzo, Egrifta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.